SEC Form 4 · accession 0001140361-15-045982
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Graham G Miao
Officer — CFO
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 28, 2015 | F | 69,020 | $0.53 | D | 142,852 | D | |
| Common StockF1 | holding | — | — | — | 211,872 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 41,899 restricted stock units ("RSUs") that were scheduled to vest on October 20, 2017 and 147,973 restricted shares of common stock that were scheduled to vest on February 24, 2018. The RSUs and restricted shares vested on December 22, 2015 as a result of the Company's sale of its Commercial Services business.
- F2Shares that were withheld on December 28, 2015 to satisfy the payroll tax obligations in connection with the vesting of 41,899 RSUs and 147,973 restricted shares of common stock triggered by the Company's sale of its Commercial Services business on December 22, 2015.